Viewing StudyNCT02624037



Ignite Creation Date: 2024-05-06 @ 7:53 AM
Last Modification Date: 2024-10-26 @ 11:53 AM
Study NCT ID: NCT02624037
Status: COMPLETED
Last Update Posted: 2021-05-18
First Post: 2015-12-03

Brief Title: Precision IFX Using a Dashboard to Individualize Infliximab Dosage
Sponsor: Icahn School of Medicine at Mount Sinai
Organization: Icahn School of Medicine at Mount Sinai

Conditions & Keywords Data

Conditions:
Name
Inflammatory Bowel Disease
Keywords:
Name View
Crohns Disease View
Pharmacokinetics Individualized Dosage Dashboard System View
Remicade Infliximab View
Inflammatory Bowel Disease Ulcerative Colitis View